Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

A double-blind placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disorders.

Hollander E, Soorya L, Chaplin W, Anagnostou E, Taylor BP, Ferretti CJ, Wasserman S, Swanson E, Settipani C.

Am J Psychiatry. 2012 Mar;169(3):292-9. doi: 10.1176/appi.ajp.2011.10050764. Erratum in: Am J Psychiatry. 2012 May;169(5):540.

PMID:
22193531
2.

Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism.

King BH, Hollander E, Sikich L, McCracken JT, Scahill L, Bregman JD, Donnelly CL, Anagnostou E, Dukes K, Sullivan L, Hirtz D, Wagner A, Ritz L; STAART Psychopharmacology Network.

Arch Gen Psychiatry. 2009 Jun;66(6):583-90. doi: 10.1001/archgenpsychiatry.2009.30.

3.

Baseline factors predicting placebo response to treatment in children and adolescents with autism spectrum disorders: a multisite randomized clinical trial.

King BH, Dukes K, Donnelly CL, Sikich L, McCracken JT, Scahill L, Hollander E, Bregman JD, Anagnostou E, Robinson F, Sullivan L, Hirtz D.

JAMA Pediatr. 2013 Nov;167(11):1045-52. doi: 10.1001/jamapediatrics.2013.2698.

PMID:
24061784
4.

A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism.

Hollander E, Phillips A, Chaplin W, Zagursky K, Novotny S, Wasserman S, Iyengar R.

Neuropsychopharmacology. 2005 Mar;30(3):582-9.

5.

Sertraline and fluoxetine treatment of obsessive-compulsive disorder: results of a double-blind, 6-month treatment study.

Bergeron R, Ravindran AV, Chaput Y, Goldner E, Swinson R, van Ameringen MA, Austin C, Hadrava V.

J Clin Psychopharmacol. 2002 Apr;22(2):148-54.

PMID:
11910259
6.

A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder.

Hollander E, Koran LM, Goodman WK, Greist JH, Ninan PT, Yang H, Li D, Barbato LM.

J Clin Psychiatry. 2003 Jun;64(6):640-7.

PMID:
12823077
7.

A randomized controlled clinical trial of citalopram versus fluoxetine in children and adolescents with obsessive-compulsive disorder (OCD).

Alaghband-Rad J, Hakimshooshtary M.

Eur Child Adolesc Psychiatry. 2009 Mar;18(3):131-5. doi: 10.1007/s00787-007-0634-z. Epub 2009 Feb 3.

PMID:
19190958
8.

Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial.

Geller DA, Hoog SL, Heiligenstein JH, Ricardi RK, Tamura R, Kluszynski S, Jacobson JG; Fluoxetine Pediatric OCD Study Team.

J Am Acad Child Adolesc Psychiatry. 2001 Jul;40(7):773-9.

PMID:
11437015
9.

Fluoxetine for Autistic Behaviors (FAB trial): study protocol for a randomized controlled trial in children and adolescents with autism.

Mouti A, Reddihough D, Marraffa C, Hazell P, Wray J, Lee K, Kohn M.

Trials. 2014 Jun 16;15:230. doi: 10.1186/1745-6215-15-230.

10.

In a double-blind, randomized and placebo-controlled trial, adjuvant memantine improved symptoms in inpatients suffering from refractory obsessive-compulsive disorders (OCD).

Haghighi M, Jahangard L, Mohammad-Beigi H, Bajoghli H, Hafezian H, Rahimi A, Afshar H, Holsboer-Trachsler E, Brand S.

Psychopharmacology (Berl). 2013 Aug;228(4):633-40. doi: 10.1007/s00213-013-3067-z. Epub 2013 Mar 23.

PMID:
23525525
11.

Fluoxetine in children and adolescents with OCD: a placebo-controlled trial.

Liebowitz MR, Turner SM, Piacentini J, Beidel DC, Clarvit SR, Davies SO, Graae F, Jaffer M, Lin SH, Sallee FR, Schmidt AB, Simpson HB.

J Am Acad Child Adolesc Psychiatry. 2002 Dec;41(12):1431-8.

PMID:
12447029
12.

Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder.

Riddle MA, Scahill L, King RA, Hardin MT, Anderson GM, Ort SI, Smith JC, Leckman JF, Cohen DJ.

J Am Acad Child Adolesc Psychiatry. 1992 Nov;31(6):1062-9.

PMID:
1429406
13.

Efficacy of fluoxetine in Austrian patients with obsessive-compulsive disorder.

Zitterl W, Meszaros K, Hornik K, Twaroch T, Dossenbach M, Zitterl-Eglseer K, Zapotoczky HG.

Wien Klin Wochenschr. 1999 Jun 4;111(11):439-42.

PMID:
10420495
14.

Fluoxetine versus placebo in posttraumatic stress disorder.

Martenyi F, Brown EB, Zhang H, Prakash A, Koke SC.

J Clin Psychiatry. 2002 Mar;63(3):199-206.

PMID:
11926718
15.

A double-masked, placebo-controlled study of fluoxetine for hypochondriasis.

Fallon BA, Petkova E, Skritskaya N, Sanchez-Lacay A, Schneier F, Vermes D, Cheng J, Liebowitz MR.

J Clin Psychopharmacol. 2008 Dec;28(6):638-45. doi: 10.1097/JCP.0b013e31818d21cf.

PMID:
19011432
16.

Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial.

March JS, Biederman J, Wolkow R, Safferman A, Mardekian J, Cook EH, Cutler NR, Dominguez R, Ferguson J, Muller B, Riesenberg R, Rosenthal M, Sallee FR, Wagner KD, Steiner H.

JAMA. 1998 Nov 25;280(20):1752-6. Erratum in: JAMA 2000 Mar 8;283(10):1293.

PMID:
9842950
17.

A double-blind trial of fluoxetine in pathologic skin picking.

Simeon D, Stein DJ, Gross S, Islam N, Schmeidler J, Hollander E.

J Clin Psychiatry. 1997 Aug;58(8):341-7.

PMID:
9515971
18.

A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder.

Phillips KA, Albertini RS, Rasmussen SA.

Arch Gen Psychiatry. 2002 Apr;59(4):381-8.

PMID:
11926939
20.

Clinical characteristics of response to fluoxetine treatment of obsessive-compulsive disorder.

Ackerman DL, Greenland S, Bystritsky A.

J Clin Psychopharmacol. 1998 Jun;18(3):185-92.

PMID:
9617976
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk